Skip to content

Study · Case report or series · n = 1 · 2025

2 results

Use of semaglutide in a 54-year-old patient with cocaine abuse and weight loss: a case report.

Romeo VM

Journal of medical case reports17 Feb 2025Cited by 6 (Europe PMC)

PMID39962582 (opens in a new tab)PMCIDPMC11834608 (opens in a new tab)DOI10.1186/s13256-025-05049-w (opens in a new tab)PepBankPUB-39962582
Read at sourcePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In one patient with obesity and a history of cocaine abuse, subcutaneous semaglutide for 12 weeks was followed by significant weight loss.

    In plain wordsIn one patient with obesity and cocaine abuse, weight fell significantly during 12 weeks of semaglutide.

    Peptide
    Semaglutide
    Outcome
    DecreaseBody weight
    Study

    n = 1

    Outcome group
    Body weight · Metabolic and weight
    Studied dose
    Dose not stated · subcutaneous · 12 weeksAs given in this study (human).

    Source sentences

    Summary
    The patient demonstrated significant weight loss and a marked reduction in cocaine craving.
    2 context sentences
    Summary · context
    This case report discusses the efficacy of semaglutide in a 54-year-old Caucasian patient with a history of cocaine abuse and obesity.
    Summary · context
    Subcutaneous semaglutide was administered, as per guidelines, with a progressive weekly increase for a total of 12 weeks.
  2. 02HumanCase report or seriesEfficacy outcome

    In one patient with obesity and a history of cocaine abuse, subcutaneous semaglutide for 12 weeks was followed by a marked reduction in cocaine craving.

    In plain wordsIn one patient with obesity and cocaine abuse, cocaine craving fell markedly during 12 weeks of semaglutide.

    Peptide
    Semaglutide
    Outcome
    DecreaseCocaine craving
    Study

    n = 1

    Outcome group
    Addiction, withdrawal and alcohol intake · Mental health and mood
    Studied dose
    Dose not stated · subcutaneous · 12 weeksAs given in this study (human).

    Source sentences

    Summary
    a marked reduction in cocaine craving.
    2 context sentences
    Summary · context
    This case report discusses the efficacy of semaglutide in a 54-year-old Caucasian patient with a history of cocaine abuse and obesity.
    Summary · context
    Subcutaneous semaglutide was administered, as per guidelines, with a progressive weekly increase for a total of 12 weeks.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.